|
|||||
|
|
Safety and efficacy of BAY 81‐8973 for surgery in previously treated patients with haemophilia A: results of the LEOPOLD clinical trial programme |
|
| Authors: | J. Oldenburg J. Windyga K. Hampton S. Lalezari D. Tseneklidou‐Stoeter H. Beckmann M. Maas Enriquez |
| Affiliation: | 1. University Clinic Bonn, Bonn, Germany;2. Institute of Hematology and Transfusion Medicine, Warsaw, Poland;3. Sheffield Haemophilia and Thrombosis Center, Sheffield, UK;4. National Hemophilia Center, Chaim Sheba Medical Center, Tel Hashomer, Israel;5. Bayer Pharma AG, Berlin, Germany;6. Bayer Pharma AG, Wuppertal, Germany |
| Abstract: | |
| Keywords: | children clinical trial haemophilia A haemostasis recombinant FVIII surgery |